Farreny A, Aguado J, Ochoa S, Haro JM, Usall J. The role of negative symptoms in the context of cognitive remediation for schizophrenia. Schizophr Res. 2013 Oct;150(1):58-63.
Farreny A, Aguado J, Ochoa S, Huerta-Ramos E, Marsà F, López-Carrilero R, Carral V, Haro JM, Usall J. REPYFLEC cognitive remediation group training in schizophrenia: looking for an integrative approach. Schizophr Res. 2012 Dec;142(1-3):137-44. doi: 10.1016/j.schres.2012.08.035.
Graham CN, Mauskopf J, Lawson AH, Ascher-Svanum H, Bruhn D, Watson PR. Validating an industry-sponsored model comparing the cost-effectiveness of atypical antipsychotics in the treatment of schizophrenia. Schizophr Res. 2010 Apr 1;117(2-3):398-9.
Beach RH, Poulos C, Pattanayak SK. Agricultural household response to avian influenza prevention and control policies. J Agr Appl Econ. 2007 Aug 1;39(2):301-11.
Rousu MC, Monchuk DC, Shogren JF, Kosa KM. Consumer willingness to pay for “second generation” genetically engineered products and the role of market information. J Agr Appl Econ. 2005 Dec;37(3):647-57. doi: 10.1017/S1074070800027140